Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.
about
Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphismsInteractions between Myc and Mediators of Inflammation in Chronic Liver DiseasesAdiponectin serum level in chronic hepatitis C infection and therapeutic profileImmuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexusAntioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C.Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients.Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicityPositioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression.Molecular and contextual markers of hepatitis C virus and drug abuse.Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis CA Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia.CCL5: a double-edged sword in host defense against the hepatitis C virus.The role of chemokines in acute and chronic hepatitis C infection.Association of plasma interleukin-18 levels and polymorphisms in interleukin-18 gene with outcomes of hepatitis C virus infections: a meta-analysis.Hepatitis C virus infection induces elevation of CXCL10 in human brain microvascular endothelial cells.Increased Spontaneous Programmed Cell Death Is Associated with Impaired Cytokine Secretion in Peripheral Blood Mononuclear Cells from Hepatitis C Virus-Positive Patients.Clinical significance and functional studies of myeloid-derived suppressor cells in chronic hepatitis C patients.Nutrition intervention: a strategy against systemic inflammatory syndrome.Twelve potential fibrosis markers to differentiate mild liver fibrosis from cirrhosis in patients infected with chronic hepatitis C genotype 1.The Clinical Importance of Cystatin C and Hepatic Artery Resistive Index in Liver Cirrhosis
P2860
Q26738545-DC092680-5520-48A4-860C-25EA2C275768Q26778328-BB2AAB7F-8BF0-49E0-B68F-09C1B401F5D1Q26827639-C0E6AEC7-88A3-409B-A96A-B4FDE2FF7FDAQ26991958-E538DB8E-413E-4A95-8A28-9194ED230246Q33894202-8B4E5F4F-7DCC-4E09-8EE8-6F5C3F0886B6Q34959537-E3CE80CD-18BC-4D0A-BBBE-CB19AA857145Q35007676-94226DAE-7974-46AB-8EF1-AA972A9A1125Q35044131-95507FE2-33E4-4C3C-9100-368B5950E2D3Q35660841-938F2D07-3E41-46C2-89F6-06CF9A35AD31Q35810531-3C297612-53D8-4C95-A457-5F5A075B4A38Q37197025-A1E2A88C-7297-4327-9CDB-FF03457C2EA7Q37402466-181F5EDC-DE2B-4F47-A082-678EF262CD19Q37952808-56B83AC1-1F50-4D93-8CD1-677CAF95A71EQ38129709-C2C2E995-0C21-4177-A43A-8282DED7CE05Q38218268-C810E9A7-8116-4A1C-9B34-F79AD463C84EQ38792584-93DAEF07-774E-4F50-8DA0-86DD284B47B1Q40287814-156DAE71-0943-47CC-A9BC-986682D2513EQ42277377-ED521226-5D18-4979-BB0D-2C855A1FAC9FQ42703392-35A11F88-CF53-4EFA-B436-67A6AB0C1D05Q43033068-A6C77409-E8E6-4AA5-A10E-777452BCEC59Q57825459-DFB0210E-94A8-4EA8-91CD-77E9F903CF4C
P2860
Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.
@en
type
label
Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.
@en
prefLabel
Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.
@en
P2093
P1476
Cytokine--chemokine and apoptotic signatures in patients with hepatitis C.
@en
P2093
Cristhian Trepo
Dominique Valla
Gad G Katz
Hemda Schmilovitz-Weiss
Izabella M Malkiewicz
Jean-Pierre Benhamou
Lawrence Cohen
Manuela G Neuman
Marc Bourliere
Mary Morgan
P304
P356
10.1016/J.TRSL.2006.11.002
P577
2007-03-01T00:00:00Z